Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The β₁-, β₂-, and α₁-adrenergic receptors are members of the G protein-coupled receptor (GPCR) superfamily that mediate the "fight or flight" responses of the sympathetic nervous system. β₁-adrenergic receptors are primarily located in the heart, where they increase heart rate and contractility. β₂-adrenergic receptors are found in the lungs, vasculature, and other tissues, mediating smooth muscle relaxation and metabolic effects. α₁-adrenergic receptors are present on vascular smooth muscle and other tissues, causing vasoconstriction and regulating systemic vascular resistance. These receptors are common drug targets in cardiovascular, respiratory, and urologic medicine, but subtype selectivity and systemic effects must be carefully managed due to widespread receptor distribution and overlapping physiological roles[2][3][4][5].
Agonism: stimulate receptor to activate downstream signaling (Gs or Gq protein leading to cAMP or IP₃/DAG signaling)[2][4][5] Antagonism: block endogenous catecholamine effects by competing for the binding site Inverse agonism (less common): stabilize the inactive receptor conformation
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on β₁-, β₂-, and α₁-adrenergic receptors (β₁-AR, β₂-AR, α₁-AR).